CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 133 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,947,744 | +4.3% | 125,742 | +7.3% | 0.00% | 0.0% |
| Q1 2024 | $1,867,403 | -5.2% | 117,152 | 0.0% | 0.00% | 0.0% |
| Q4 2023 | $1,969,325 | +49.0% | 117,152 | +3.6% | 0.00% | 0.0% |
| Q3 2023 | $1,321,578 | -67.1% | 113,052 | -62.2% | 0.00% | -50.0% |
| Q2 2023 | $4,019,662 | +77.5% | 299,082 | +118.9% | 0.00% | +100.0% |
| Q1 2023 | $2,265,193 | -19.2% | 136,622 | -9.4% | 0.00% | 0.0% |
| Q4 2022 | $2,804,006 | +41.3% | 150,753 | -2.6% | 0.00% | 0.0% |
| Q3 2022 | $1,985,000 | -45.3% | 154,699 | -70.1% | 0.00% | -50.0% |
| Q2 2022 | $3,629,000 | +225.8% | 517,711 | +285.2% | 0.00% | – |
| Q1 2022 | $1,114,000 | +22.8% | 134,400 | +0.4% | 0.00% | – |
| Q4 2021 | $907,000 | +27.7% | 133,900 | 0.0% | 0.00% | – |
| Q3 2021 | $710,000 | -13.0% | 133,900 | -5.7% | 0.00% | – |
| Q2 2021 | $816,000 | +24.8% | 141,948 | 0.0% | 0.00% | – |
| Q1 2021 | $654,000 | +24.8% | 141,948 | -9.5% | 0.00% | – |
| Q4 2020 | $524,000 | +18.6% | 156,787 | +5.4% | 0.00% | – |
| Q3 2020 | $442,000 | -35.7% | 148,800 | 0.0% | 0.00% | – |
| Q2 2020 | $687,000 | +19.9% | 148,800 | 0.0% | 0.00% | – |
| Q1 2020 | $573,000 | +2.7% | 148,800 | 0.0% | 0.00% | – |
| Q4 2019 | $558,000 | -29.4% | 148,800 | 0.0% | 0.00% | – |
| Q3 2019 | $790,000 | +38.4% | 148,800 | 0.0% | 0.00% | – |
| Q2 2019 | $571,000 | +25.8% | 148,800 | +67.0% | 0.00% | – |
| Q1 2019 | $454,000 | +410.1% | 89,100 | +91.6% | 0.00% | – |
| Q4 2018 | $89,000 | -35.5% | 46,500 | +27.7% | 0.00% | – |
| Q3 2018 | $138,000 | +51.6% | 36,400 | +24.7% | 0.00% | – |
| Q2 2018 | $91,000 | +116.7% | 29,200 | +65.0% | 0.00% | – |
| Q1 2018 | $42,000 | +2.4% | 17,700 | +70.2% | 0.00% | – |
| Q4 2017 | $41,000 | +36.7% | 10,400 | -11.9% | 0.00% | – |
| Q3 2017 | $30,000 | -9.1% | 11,800 | 0.0% | 0.00% | – |
| Q2 2017 | $33,000 | +3200.0% | 11,800 | +3141.8% | 0.00% | – |
| Q1 2014 | $1,000 | 0.0% | 364 | 0.0% | 0.00% | – |
| Q4 2013 | $1,000 | 0.0% | 364 | 0.0% | 0.00% | – |
| Q3 2013 | $1,000 | – | 364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 17,875,655 | $94,920,000 | 9.39% |
| TANAKA CAPITAL MANAGEMENT INC | 283,334 | $1,505,000 | 4.86% |
| GABLES CAPITAL MANAGEMENT INC. | 490,564 | $2,606,000 | 1.84% |
| MANGROVE PARTNERS IM, LLC | 2,508,838 | $13,322,000 | 1.61% |
| Broadfin Capital, LLC | 880,303 | $4,674,000 | 0.86% |
| Atom Investors LP | 1,012,355 | $5,376,000 | 0.37% |
| Capital Impact Advisors, LLC | 179,868 | $948,000 | 0.36% |
| KNOTT DAVID M | 151,415 | $804,000 | 0.34% |
| EMERALD ADVISERS, LLC | 1,175,958 | $6,244,000 | 0.29% |
| CADENCE CAPITAL MANAGEMENT LLC | 371,075 | $1,970,000 | 0.28% |